Conserved Epitopes in Bacterial Lipopolysaccharides and Cross-Reactive Antibodies in the Treatment of Endotoxicosis and Gram-Negative Septic Shock

Fighting Infection in the 21st Century

Volumn , Issue , 2008, Pages 143-178

  Müller Loennies, Sven ^a   di Padova, Franco ^b   Brade, Lore ^a   Heumann, Didier ^c   Rietschel, Ernst Theodor ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b Preclinical Research   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cross reactive antibodies; Endotoxicosis; Lipid; Lipopolysaccharides; Microbes

Indexed keywords

EID: 84948761585     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695951.ch9     Document Type: Chapter

References (180)

1. Bahrami, S., Redl, H., Yao, Y. M. & Schlag, G. (1996). Involvement of bacteria/endotoxin translocation in the development of multiple organ failure. Current Topics in Microbiology and Immunology 216, 239-258.
2. Bahrami, S., Yao, Y. M., Leichtfried, G., Redl, H., Schlag, G. & Di Padova, F. E. (1997). Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats. Critical Care Medicine 25, 1030-1036.
3. Bailat, S., Neumann, D., Le Roy, D., Baumgartner, J.D., Rietschel, E. Th., Glauser, M. P. & Di Padova, F. E. (1997). Similarities and disparities between core-specific and O-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infection and Immunity 65, 811-814.
4. Baumberger, C., Ulevitch, R. J.& Dayer, J.M. (1991). Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 59, 378-383.
5. Baumgartner, J.D.& Glauser, M. P. (1993). Immunotherapy of endotoxemia and septicemia. Immunobiology 187, 464-477.
6. Baumgartner, J.D., Heumann, D., Calandra, T. & Glauser, M. P. (1991). Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. Journal of Infectious Diseases 163, 769-772.
7. Beamer, L. J., Carroll, S. F. & Eisenberg, D. (1997). Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276, 1861-1864.
8. Beutler, B. & Cerami, A. (1988). Tumor necrosis, cachexia shock, and inflammation: a common mediator. Annual Reviews of Biochemistry 57, 505-518.
9. Bhat, N. M., Bieber, M. M., Chapman, C. J., Stevenson, F. K. & Teng, N. N. (1993). Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. Journal of Immunology 151, 5011-5021.
10. Bigham, E. C., Gragg, C. E., Hall, W. R., Kelsey, J. E., Mallory, W. R., Richardson, D. C., Benedict, C. & Ray, P. H. (1984). Inhibition of arabinose 5-phosphate isomerase.An approach to the inhibition of bacterial lipopolysaccharide biosynthesis. Journal of Medicinal Chemistry 27, 717-726.
11. Bone, R. C., Balk, R. A., Fein, A. M. & 7 other authors (1995). A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. Critical Care Medicine 23, 994-1006.
12. Boulukos, K. E., Pognonec, P., Sariban, E., Bailly, M., Lagrou, C. & Ghysdael, J. (1990). Rapid and transient expression of Ets2 in mature macrophages following stimulation with cMGF, LPS, and PKC activators. Genes & Development 4, 401-409.
13. Brabetz, W. & Rietschel, E. Th. (1999). Bakterielle Endotoxine: Chemische Konstitution und Biologische Wirkung. Nordrhein-Westfälische Akademie der Wissenschaften.Vorträge, N 440.Westdeutscher Verlag.
14. Brade, L., Rietschel, E. Th., Kusumoto, S., Shiba, T.& Brade, H. (1986). Immunogenicity and antigenicity of synthetic Escherichia coli lipid A. Infection and Immunity 51, 110-114.
15. Brade, L., Brandenburg, K., Kuhn, H. M., Kusumoto, S., Macher, I., Rietschel, E.T.& Brade, H. (1987a). The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infection and Immunity 55, 2636-2644.
16. Brade, L., Kosma, P., Appelmelk, B. J., Paulsen, H. & Brade, H. (1987b). Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-?-manno-octulosonate region of bacterial lipopolysaccharide. Infection and Immunity 55, 462-466.
17. Brade, L., Holst, O. & Brade, H. (1993). An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies. Infection and Immunity 61, 4514-4517.
18. Brade, L., Engel, R., William, J. C. & Rietschel, E. Th. (1997). A nonsubstituted primary hydroxyl group in the 6? position of free lipid A is required for binding of lipid A monoclonal antibodies. Infection and Immunity 65, 3961-3965.
19. Braude, A. I. & Douglas, H. (1972). Passive immunization against the local Shwartzman reaction. Journal of Immunology 108, 505-512.
20. Brearly, S., Harris, R. I., Stone, P. C.W.& Keighley, M. R.B. (1985). Endotoxin levels in portal and systemic blood. Digestive Surgery 2, 70-72.
21. Bruins, S. C., Stumacher, R., Johns, M.A.& McCabe, W.R. (1977). Immunization with R mutants of Salmonella minnesota. Infection and Immunity 17, 16-20.
22. Cauwels, A., Frei, K., Sansano, S., Fearns, C., Ulevitch, R., Zimmerli, W. & Landmann, R. (1999). The origin and function of soluble CD14 in experimental bacterial meningitis. Journal of Immunology 162, 4762-4772.
23. Chow, J. C., Young, D.W., Golenbock, D.T., Christ, W. J. & Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharideinduced signal transduction. Journal of Biological Chemistry 274, 10689-10692.
24. Christ, W. J., Asano, O., Robidoux, A. L.& 19 other authors (1995). E5531, a pure endotoxin antagonist of high potency. Science 268, 80-83.
25. Claesson, A., Luthman, K., Gustafsson, K.& Bondesson, G. (1987). A 2-deoxy analogue of KDO as the first inhibitor of the enzyme CMPKDO synthetase. Biochemical and Biophysical Research Communications 143, 1063-1068.
26. Coleman, D. L., Bartiss, A. H., Sukhatme, V. P., Liu, J. & Rupprecht, H.D. (1992). Lipopolysaccharide induces Egr-1 mRNA and protein in murine peritoneal macrophages. Journal of Immunology 149, 3045-3051.
27. Collart, M.A., Belin, D., Vassalli, J.D. & Vassalli, P. (1987). Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. Journal of Immunology 139, 949-955.
28. Cornelissen, J. J., Mäkel, I., Algra, A., Benaissa-Trouw, B. J., Schellekens, J. F. P., Kraaijeveld, C. A. & Verhoef, J. (1993). Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. Journal of Infectious Diseases 167, 876-881.
29. Cygler, M., Rose, D. R. & Bundle, D. R. (1991). Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253, 442-445.
30. Daniel-Issakani, S., Spiegel, A. M. & Strulovici, B. (1989). Lipopolysaccharide response is linked to the GTP binding protein, Gi2, in the promonocytic cell line U937. Journal of Biological Chemistry 264, 20240-20247.
31. Davis, C. E., Ziegler, E. J. & Arnold, K. F. (1978). Neutralization of meningococcal endotoxin by antibody to core glycolipid. Journal of Experimental Medicine 147, 1007-1017.
32. Dendorfer, U., Oettgen, P.& Libermann, T. A. (1994). Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Molecular and Cellular Biology 14, 4443-4454.
33. Ding, A., Hwang, S., Lander, H.M.& Xie, Q.W. (1995). Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. Journal of Leukocyte Biology 57, 174-179.
34. Di Padova, F. E., Brade, H., Barclay, R. & 8 other authors (1993). A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infection and Immunity 61, 3863-3872.
35. Di Padova, F., Gram, H., Barclay, G. R., Poxton, I. R., Liehl, E. & Rietschel, E. Th. (1996). Monoclonal antibodies to endotoxin core as a new approach in endotoxemia therapy. In Novel Therapeutic Strategies in the Treatment of Sepsis, pp. 13-31. Edited by D. C.Morrison & J. L.Ryan.New York:Marcel Dekker.
36. Dong, Z.Y., Lu, S. & Zhang, Y. H. (1989). Effects of pretreatment with protein kinase C activators on macrophage activation for tumor cytotoxicity, secretion of tumor necrosis factor, and its mRNA expression. Immunobiology 179, 382-394.
37. Dong, Z., O'Brian, C. A. & Fidler, I. J. (1993). Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. Journal of Leukocyte Biology 53, 53-60.
38. Dong, Z., Qi, X. & Fidler, I. J. (1993). Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. Journal of Experimental Medicine 177, 1071-1077.
39. Dunn, D. L. & Ferguson, R. M. (1982). Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5. Surgery 92, 212-219.
40. Edmond, D. M., Poxton, I.R.& Di Padova, F. (1993). The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli grown in sub-MICs of temocillin and other antibiotics. Journal of Antimicrobial Chemotherapy 31, 673-680.
41. Elsbach, P.& Weiss, J. (1993). The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187, 417-429.
42. Evans, T. J., Carpenter, A., Moyes, D., Martin, R. & Cohen, J. (1995). Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis. Journal of Infectious Diseases 171, 153-160.
43. Feist, W., Ulmer, A. J., Wang, M. H. & 9 other authors (1992). Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1 and interleukin 6 by synthetic precursor Ia of lipid A. FEMS Microbiology Immunology 89, 73-90.
44. Ferguson-Chanowitz, K. M., Katocs, A. S., Jr, Pickett, W. C., Kaplan, J.B., Sass, P. M., Oronsky, A. L. & Kerwar, S. S. (1990). Plateletactivating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-a in the plasma of mice treated with endotoxin. Journal of Infectious Diseases 162, 1081-1086.
45. Flad, H.-D., Loppnow, H., Rietschel, E. Th.& Ulmer, A. J. (1993). Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187, 303-316.
46. Flegel, W. A., Baumstark, M.A., Weinstock, C., Berg, A.& Northoff, H. (1993). Prevention of endotoxin-induced monokine release by human low-and high-density lipoproteins and by apolipoprotein A. Infection and Immunity 61, 5140-5146.
47. Freudenberg, M.A., Bog-Hansen, T. C., Back, U. & Galanos, C. (1980). Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infection and Immunity 28, 373-380.
48. Freudenberg, M.A., Keppler, D. & Galanos, C. (1986). Requirement for lipopolysaccharideresponsive macrophages in galactosamineinduced sensitization to endotoxin. Infection and Immunity 51, 891-895.
49. Freudenberg, N., Piotraschke, J., Galanos, C., Sorg, C., Askaryar, F. A., Klosa, B., Usener, H. U. & Freudenberg, M.A. (1992). The role of macrophages in the uptake of endotoxin by the mouse liver. Virchows Archiv B Cell Pathology 61, 343-349.
50. Fujihara, M., Muroi, M., Muroi, Y., Ito, N.& Suzuki, T. (1993). Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). Journal of Biological Chemistry 268, 14898-14905.
51. Fujihara, M., Connolly, N., Ito, N. & Suzuki, T. (1994). Properties of protein kinase C isoforms (beta II, epsilon, and zeta) in a macrophage cell line (J774) and their roles in LPS-induced nitric oxide production. Journal of Immunology 152, 1898-1906.
52. Galanos, C., Lüderitz, O.& Westphal, O. (1971). Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. European Journal of Biochemistry 24, 116-122.
53. Galanos, C., Rietschel, E. Th., Lüderitz, O.& Westphal, O. (1972). Biological activities of lipid A complexed with bovine-serum albumin. European Journal of Biochemistry 31, 230-233.
54. Galanos, C., Lüderitz, O., Rietschel, E. Th.& Westphal, O. (1977). Newer aspects of the chemistry and biology of bacterial lipopolysaccharides with special reference to their lipid A component. In Biochemistry of Lipids II, pp. 239-371. Edited by T.W. Goodwin. Baltimore:University Park Press.
55. Galanos, C., Lehmann, V., Lüderitz, O. & 7 other authors (1984). Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. European Journal of Biochemistry 140, 221-227.
56. Galanos, C., Lüderitz, O., Rietschel, E. Th. & 9 other authors (1985). Synthetic and natural Escherichia coli lipid A express identical endotoxic activities. European Journal of Biochemistry 148, 1-5.
57. Giroir, B. P., Quint, P. A., Barton, P.& 7 other authors (1997). Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 350, 1439-1443.
58. Glaser, K.B., Asmis, R. & Dennis, E. A. (1990). Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Plateletactivating factor receptor activation and regulation of phospholipase A2. Journal of Biological Chemistry 265, 8658-8664.
59. Goldman, R., Kohlbrenner, W., Lartey, P.& Pernet, A. (1987). Antibacterial agents specifically inhibiting lipopolysaccharide synthesis. Nature 329, 162-164.
60. Greisman, S. E. & Johnston, C.A. (1988). Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality. Journal of Infectious Diseases 157, 54-64.
61. Hambleton, J., McMahon, M. & DeFranco, A. L. (1995). Activation of Raf-1 and mitogen Kirschning, C. J., Wesche, H., Merrill, A.T.& Rothe, M. (1998). Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. Journal of Experimental Medicine 188, 2091-2097.
62. Kitchens, R. L., Ulevitch, R. J.& Munford, R.S. (1992). Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. Journal of Experimental Medicine 176, 485-494.
63. Knirel, Y.A.& Kochetkov, N. K. (1994). The structure of lipopolysaccharides in Gramnegative bacteria. III. The structure of Oantigens. Biochemistry (Moscow) 59, 1325-1383.
64. Kominato, Y., Galson, D., Waterman, W. R., Webb, A.C.& Auron, P. E. (1995). Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Molecular and Cellular Biology 15, 59-68.
65. Kuhn, H.-M. (1993). Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides. Infection 21, 179-186.
66. Kuhn, H.-M., Brade, L., Appelmelk, B. J., Kusumoto, S., Rietschel, E. Th. & Brade, H. (1992). Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infection and Immunity 60, 2201-2210.
67. Kunkel, S. L., Spengler, M., May, M.A., Spengler, R., Larrick, J.& Remick, D. (1988). Prostaglandin E2 regulates macrophagederived tumor necrosis factor gene expression. Journal of Biological Chemistry 263, 5380-5384.
68. Lamping, N., Dettmer, R., Schroeder, N.W., Pfeil, D., Hallatschek, W., Burger, R.& Schuhmann, R. R. (1998). LPS-binding protein (LBP) protects mice from septic shock caused by LPS or Gram-negative bacteria. Journal of Clinical Investigation 101, 2065-2071.
69. Law, B. J.& Marks, M. I. (1985). Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli J5, as measured by ELISA. Journal of Infectious Diseases 151, 988-994.
70. Lee, J.D., Dato, K., Tobias, P. S., Kirkland, T. N.& Ulevitch, R. J. (1992). Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. Journal of Experimental Medicine 175, 1697-1705.
71. Lee, J.D., Kravchenko, V., Kirkland, T. N., Han, J., Mackman, N., Moriarty, A., Leturcq, D., Tobias, P. S.& Ulevitch, R. J. (1993). Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proceedings of the National Academy of Sciences, USA 90, 9930-9934.
72. Lehmann, V., Freudenberg, M.A.& Galanos, C. (1987). Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and ?-galactosamine-treated mice. Journal of Experimental Medicine 165, 657-663.
73. Levin, J., Alving, C. R., Munford, R. S. & Redl, H. (editors) (1995). Bacterial Endotoxins. Lipopolysaccharides from Genes to Therapy. Progress in Clinical and Biological Research, vol. 392. New York:Wiley-Liss.
74. Levine, M. (1987). Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. Journal of Infectious Diseases 155, 377-389.
75. Lodie, T. A., Savedra, R. J., Golenbock, D.T., Van Beveren, C. P., Maki, R. A. & Fenton, M. J. (1997). Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. Journal of Immunology 158, 1848-1856.
76. Loppnow, H., Brade, H., Dürrbaum, I., Dinarello, C. A., Kusumoto, S., Rietschel, E. Th. & Flad, H.-D. (1989). Interleukin 1 induction capacity of defined lipopolysaccharide partial structures. Journal of Immunology 142, 3229-3238.
77. Lynn, W. A. & Golenbock, D.T. (1992). Lipopolysaccharide antagonists. Immunology Today 13, 271-276.
78. McCabe, W.R. (1992). Antibody to endotoxin in the treatment of gram-negative sepsis. Journal of the American Medical Association 267, 2325.
79. McCloskey, R.V., Straube, R. C., Sanders, C., Smith, S. M. & Smith, C. R. (1994). Treatment activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. Journal of Experimental Medicine 182, 147-154.
80. Hampton, R.Y. & Raetz, C. R. (1991). Macrophage catabolism of lipid A is regulated by endotoxin stimulation. Journal of Biological Chemistry 266, 19499-19509.
81. Han, J., Lee, J.D., Bibbs, L.& Ulevitch, R. J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
82. Haziot, A., Chen, E., Ferrero, E., Low, M. G., Siver, R. & Goyert, S.M. (1988). The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. Journal of Immunology 141, 547-552.
83. Heine, H., Brade, H., Kusumoto, S., Kusama, T., Rietschel, E. Th., Flad, H.D. & Ulmer, A. J. (1994). Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A. Journal of Endotoxin Research 1, 14-20.
84. Helander, I., Lindner, B., Brade, H., Altmann, K., Lindberg, A. A., Rietschel, E. Th. & Zähringer, U. (1988). Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. European Journal of Biochemistry 177, 483-492.
85. Heumann, D., Baumgartner, J.D., Jacot-Guillarmod, H. & Glauser, M. P. (1991). Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides. Journal of Infectious Diseases 163, 762-768.
86. Heumann, D., Lengacher, S., Le Roy, D., Jongeneel, C.V. & Glauser, M. P. (1998). The pathogenic role of LBP in gram-negative sepsis and septic shock. Progress in Clinical and Biological Research 397, 379-386.
87. Holst, O. & Brade, H. (1992). Chemical structure of the core region of lipopolysaccharides. In Molecular Biochemistry and Cellular Biology, pp. 135-170. Edited by D. C.Morrison & J. L. Ryan. Boca Raton, FL: CRC Press.
88. Horwitz, A. H., Williams, R. E. & Nowakowski, G. (1995). Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal permeability-increasing protein. Infection and Immunity 63, 522-527.
89. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. & Akira, S. (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 162, 3749-3752.
90. Intravenous Immunoglobulin Study Group (1992). Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. New England Journal of Medicine 327, 234-240.
91. Izbicki, J. R., Raedler, C., Anke, A.& 8 other authors (1991). Beneficial effect of liposomeencapsulated muramyl tripeptide in experimental septicemia in a porcine model. Infection and Immunity 59, 126-130.
92. Jack, R. S., Fan, X., Bernheiden, M.& 10 other authors (1997). Lipopolysaccharide-binding protein is required to combat a murine gramnegative bacterial infection. Nature 389, 742-745.
93. Jakway, J. P. & DeFranco, A. L. (1986). Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science 234, 743-746.
94. Jann, K. & Jann, B. (1984). Structure and biosynthesis of O-antigens. In Chemistry of Endotoxin, pp. 138-186. Edited by E. Th. Rietschel.Amsterdam: Elsevier.
95. Jansson, P. E., Wollin, R., Bruse, G.W.& Lindberg, A. A. (1989). The conformation of core oligosaccharides from Escherichia coli and Salmonella typhimurium lipopolysaccharides as predicted by semi-empirical calculations. Journal ofMolecular Recognition 2, 25-36.
96. Johns, M.A., Bruins, S. C.& McCabe, W.R. (1977). Immunization with R mutants of Salmonella minnesota. Infection and Immunity 17, 9-15.
97. Kauffmann, F. (1972). Serological Diagnosis of Salmonella Species. Kauffmann-White Scheme. Copenhagen:Munksgaard International Publishers.
98. Khan, S. A., Everest, P., Servos, S. & 7 other authors (1998). A lethal role for lipid A in Salmonella infections. Molecular Microbiology 29, 571-579.
99. Mamat, U., Rietschel, E. Th. & Schmidt, G. (1995). Repression of lipopolysaccharide biosynthesis in Escherichia coli by an antisense RNA of Acetobacter methanolicus phage Acm1. Molecular Microbiology 15, 1115-1125.
100. Mamat, U., Seydel, U., Grimmecke, D., Holst, O. & Rietschel, E.T. (1999). Lipopolysaccharides. In Comprehensive Natural Products Chemistry. Edited by Sir D. Barton, K.Nakanishi & O. Meth-Cohn.Vol. III, Carbohydrates and Their Derivatives Including Tannins, Cellulose, and Related Lignins, pp. 179-239. Edited by B. M. Pinto. Oxford: Elsevier.
101. Mannion, B., Kalatzis, A., Weiss, J. & Elsbach, P. (1989). Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability-increasing protein to target bacteria. Implications and use as a means of purification. Journal of Immunology 142, 2807-2812.
102. Marchant, A., Alegre, M. L., Hakim, A.& 7 other authors (1995). Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. Journal of Clinical Immunology 15, 266-273.
103. Marks, M. I., Ziegler, E. J., Douglas, H., Corbeil, L.B. & Braude, A. I. (1982). Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Journal of Clinical Investigation 69, 742-749.
104. Massamiri, T., Tobias, P. S. & Curtiss, L. K. (1997). Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. Journal of Lipid Research 38, 516-525.
105. May, M. J. & Ghosh, S. (1998). Signal transduction through NF-kappa B. Immunology Today 19, 80-88.
106. Miner, K. M., Manyak, C. L., Williams, E. & 8 other authors (1986). Characterization of murine monoclonal antibodies to Escherichia coli J5. Infection and Immunity 52, 56-62.
107. Morrison, D. C. (1998). Antibiotic-mediated release of endotoxin and the pathogenesis of Gram-negative sepsis. In Endotoxin and Sepsis, pp. 199-207. Edited by J. Levin, M. Pollack, T. Yokochi & M.Nakano.New York:Wiley-Liss.
108. Müller, J. M., Ziegler-Heitbrock, H.W.& Bäuerle, P. A. (1993). Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187, 233-256.
109. Müller-Loennies, S., Holst, O. & Brade, H. (1994). Chemical structure of the core region of Escherichia coli J-5 lipopolysaccharide. European Journal of Biochemistry 224, 751-760.
110. Müller-Loennies, S., Zähringer, U., Seydel, U., Kusumoto, S., Ulmer, A. J. & Rietschel, E.T. (1998). What we know and what we don't know about the chemical structure of lipopolysaccharide in relation to bioactivity. Progress in Clinical and Biological Research 397, 51-72.
111. Müller-Loennies, S., Holst, O., Lindner, B.& Brade, H. (1999). Isolation and structural analysis of phosphorylated oligosaccharides obtained from Escherichia coli J-5 lipopolysaccharide. European Journal of Biochemistry 260, 235-249.
112. Munford, R. S. & Hall, C. L. (1986). Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234, 203-205.
113. Munford, R. S. & Hall, C. L. (1989). Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. Journal of Biological Chemistry 264, 15613-15619.
114. Munford, R. S., Hall, C. L.& Dietschy, J.M. (1981). Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infection and Immunity 34, 835-843.
115. Newell, C. L., Deisseroth, A.B. & Lopez-Berestein, G. (1994). Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. Journal of Leukocyte Biology 56, 27-35.
116. Nichols, W. A., Raetz, C. R. H., Clementz, T., Smith, A. L., Hanson, J. A., Ketterer, M. R., Sunshine, M. & Apicella, M.A. (1997). htrb of Haemophilus influenzae. Determination of biochemical activity and effects on virulence and lipopolysaccharide toxicity. Journal of Endotoxin Research 4, 163-172.
117. Nnalue, N. A. (1998). a-GlcNAc-1A2-a-Glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly crossreactive antibodies. Infection and Immunity 66, 4389-4396.
118. Nogare, D. (1991). Southwestern internal medicine conference: septic shock. American Journal ofMedical Science 302, 50-65.
119. Olsthoorn, M. M., Petersen, B.O., Schlecht, S., Haverkamp, J., Bock, K., Thomas-Oates, J. E.& Holst, O. (1998). Identification of a novel core type in Salmonella lipopolysaccharide. Complete structural analysis of the core region of the lipopolysaccharide from Salmonella enterica sv.Arizonae O62. Journal of Biological Chemistry 273, 3817-3829.
120. Onishi, H. R., Pelak, B. A., Gerckens, L. S. & 8 other authors (1996). Antibacterial agents that inhibit lipid A biosynthesis. Science 274, 980-982.
121. Parent, J.B., Gazzano-Santoro, H., Wood, D. M., Lim, E., Pruyne, P.T., Trown, P.W.& Conlon, P. J. (1992). Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short-and long-chain smooth lipopolysaccharides. Circulatory Shock 38, 63-73.
122. Parillo, J. E. (1993). Pathogenic mechanism of septic shock. New England Journal ofMedicine 328, 1471-1477.
123. Peter, G., Chernow, M., Keating, M. H., Ryff, J. C. & Zinner, S. H. (1982). Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia. Infection 10, 228-232.
124. Peterson, A. A.& Munford, R. S. (1987). Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infection and Immunity 55, 974-978.
125. Pfeiffer, R. (1892). Untersuchungen über das Choleragift. Zeitschrift fürHygiene 11, 393-412.
126. Poltorak, A., He, X., Smirnova, I. & 11 other authors (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene. Science 282, 2085-2088.
127. Prins, J. M., van Agtmael, M.A., Kuijper, E. J., van Deventer, S. J.& Speelman, P. (1995). Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. Journal of Infectious Diseases 172, 886-891.
128. Qureshi, S.T., Lariviere, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P.& Malo, D. (1999). Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). Journal of Experimental Medicine 189, 615-625.
129. Raetz, C. R. H. (1996). Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles. In Escherichia coli and Salmonella: Cellular and Molecular Biology, pp. 1035-1063. Edited by F. C. Neidhardt and others.Washington, DC: American Society for Microbiology.
130. Raponi, G., Keller, N., Overbeek, B. P., Rozenberg-Arska, M., Torensma, R.& Verhoef, J. (1991). Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. Journal of Infectious Diseases 163, 122-127.
131. Rietschel, E. Th. & Brade, H. (1992). Bacterial endotoxins. Scientific American 267, 54-61.
132. Rietschel, E. Th. & Galanos, C. (1977). Lipid A antiserum-mediated protection against lipopolysaccharide-and lipid A-induced fever and skin necrosis. Infection and Immunity 15, 34-49.
133. Rietschel, E. Th., Brade, L., Holst, O., Kulshin, V. A., Lindner, B., Moran, A. P., Schade, U., Zähringer, U.& Brade, H. (1990). Molecular structure of bacterial endotoxin in relation to bioactivity. In Cellular and Molecular Aspects of Endotoxin Reactions, pp. 15-32. Edited by A. Nowotny, J. J. Spitzer & E. J. Ziegler. Amsterdam: Elsevier.
134. Rietschel, E. Th., Seydel, U., Zähringer, U.& 7 other authors (1991). Bacterial endotoxin: molecular relationships between structure and activity. Infectious Disease Clinics of North America 5, 753-779.
135. Rietschel, E. Th., Kirikae, T., Schade, F.U. & 9 other authors (1996a). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal 218, 217-225.
136. Rietschel, E. Th., Brade, H., Holst, O. & 19 other authors (1996b). Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Current Topics in Microbiology and Immunology 216, 39-81.
137. Robinson, M. J. & Cobb, M.H. (1997). Mitogenactivated protein kinase pathways. Current Opinion in Cell Biology 9, 180-186.
138. Romulo, R. L. C., Palardy, J. E.& Opal, S. M. (1993). Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis. Journal of Infectious Diseases 167, 126-130.
139. Rozalski, A., Brade, L., Kosma, P., Appelmelk, B. J., Krogmann, C. & Brade, H. (1989). Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype. Infection and Immunity 57, 2645-2652.
140. Sarabia-Garcia, F., Lopez-Herrera, F. J.& Pino-Gonzalez, M. S. (1994). A new synthesis for 2-deoxy-Kdo, a potent inhibitor of CMP-KDO synthetase. Tetrahedron Letters 35, 6709-6712.
141. Schlag, G., Redl, H., Davies, J. & Scannon, P. (1999). Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties. Annals of Surgery 229, 262-271.
142. Schromm, A.B., Brandenburg, K., Loppnow, H., Zähringer, U., Rietschel, E. Th., Carroll, S. F., Koch, M.H. J., Kusumoto, S. & Seydel, U. (1998). The charge of endotoxin molecules influences their conformation and interleukin-6 inducing capacity. Journal of Immunology 161, 5464-5471.
143. Schumann, R. R., Leong, S. R., Flaggs, G.W., Gray, P.W., Wright, S.D., Mathison, J. C., Tobias, P. S.& Ulevitch, R. J. (1990). Structure and function of lipopolysaccharide binding protein. Science 249, 1431-1433.
144. Schütt, C., Schilling, T., Grunwald, U., Schönfeld, W. & Krüger, C. (1992). Endotoxinneutralizing capacity of soluble CD14. Research in Immunology 143, 71-78.
145. Schwartz, R.W., Arden, W. A., Pofahl, W., Derbin, M., Oremus, R., Greenberg, R. N.& Gross, D. R. (1993). Effect of anti-lipid A monoclonal antibody (E5) on microcirculatory function during lipopolysaccharide shock. Journal of Surgical Research 54, 474-479.
146. Seydel, U., Brandenburg, K.& Rietschel, E.T. (1994). A case for an endotoxic conformation. Progress in Clinical and Biological Research 388, 17-30.
147. Shapira, L., Takashiba, S., Champagne, C., Amar, S. & Van Dyke, T. E. (1994). Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. Journal of Immunology 153, 1818-1824.
148. Siber, G. R., Kania, S. A.& Warren, H. S. (1985). Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. Journal of Infectious Diseases 152, 954-964.
149. Stegmayr, B., Björck, S., Holm, S., Nisell, J., Rydvall, A. & Settergren, B. (1992). Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scandinavian Journal of Infectious Diseases 24, 589-597.
150. Strieter, R. M., Remick, D. G., Ward, P. A., Spengler, R. N., Lynch, J. P., Larrick, J.& Kunkel, S. L. (1988). Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochemical and Biophysical Research Communications 155, 1230-1236.
151. Sunshine, M. G., Gibson, B.W., Engstrom, J. J., Nichols, W. A., Jones, B.D. & Apicella, M.A. (1997). Mutation of the htrB gene in a virulent Salmonella typhimurium strain by intergeneric transduction: strain construction and phenotypic characterization. Journal of Bacteriology 179, 5521-5533.
152. Swierzko, A., Brade, L., Brabetz, W., Zych, K., Paulsen, H. & Brade, H. (1994). Monoclonal antibodies against the heptose region of enterobacterial lipopolysaccharides. Journal of Endotoxin Research 1, 38-44.
153. Tate, W. J., Douglas, H., Braude, A. I.& Wells, W. W. (1966). Protection against lethality of E. coliendotoxin with "O" antiserum. Annals of the New York Academy of Sciences 133, 746-762.
154. Tebo, J. M., Chaoqun, W., Ohmori, Y.& Hamilton, T.A. (1994). Murine inhibitory protein-kappa B alpha negatively regulates kappa B-dependent transcription in lipopolysaccharide-stimulated RAW 264.7 macrophages. Journal of Immunology 153, 4713-4720.
155. Ulmer, A. J., Feist, W., Heine, H. & 8 other authors (1992). Modulation of endotoxininduced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Infection and Immunity 60, 5145-5152.
156. Unger, F.U. (1981). The chemistry and biological significance of 3-deoxy-?-manno-octulosonic acid (Kdo). Advances in Carbohydrate Chemistry and Biochemistry 38, 323-388.
157. Van Deventer, S. J. H., Ten Cate, J.W.& Tytgat, G. N. J. (1988). Intestinal endotoxaemia. Gastroenterology 94, 825-831.
158. Vincent, J. L. (1996). Definition and pathogenesis of septic shock. Current Topics in Microbiology and Immunology 216, 1-13.
159. Vogel, S. N. (1990). The role of cytokines in endotoxin-mediated host response. In Immunopharmacology-the Role of Cells and Cytokines in Immunity and Inflammation, pp. 238-258. Edited by J. J. Oppenheim & E. M. Shevack.New York:Oxford University Press.
160. Vogel, S. N., Johnson, D., Perera, P.-Y., Medvedev, A., Lariviere, L., Qureshi, S.T.& Malo, D. (1999). Functional characterization of the effect of the C3H/HeJ defect in mice that lack an LPSn gene: in vivo evidence for a dominant negative effect. Journal of Immunology 162, 5666-5670.
161. Weinstein, S. L., Sanghera, J. S., Lemke, K., DeFranco, A. L. & Pelech, S. L. (1992). Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogenactivated protein kinases in macrophages. Journal of Biological Chemistry 267, 14955-14962.
162. Wenzel, R. P., Pinsky, M. R., Ulevitch, R. J.& Young, L. (1996). Current understandings of sepsis. Clinical Infectious Diseases 22, 407-413.
163. Westphal, O. & Lüderitz, O. (1954). Chemische Erforschung von Lipopolysacchariden Gramnegativer Bakterien. Angewandte Chemie 66, 407-417.
164. Whitfield, C. & Valvano, M.A. (1993). Biosynthesis and expression of cell-surface polysaccharides in Gram-negative bacteria. Advances in Microbial Physiology 35, 135-246.
165. Wiese, A., Brandenburg, K., Carroll, S. F., Rietschel, E.T. & Seydel U. (1997a). Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gramnegative bacteria. Biochemistry 36, 10311-10319.
166. Wiese, A., Brandenburg, K., Lindner, B., Schromm, A.B., Carroll, S. F., Rietschel, E.T.& Seydel, U. (1997b). Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 36, 10301-10310.
167. Wiese, A., Münstermann, M., Gutsmann, T., Lindner, B., Kawahara, K., Zahringer, U.& Seydel, U. (1998). Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport. Journal ofMembrane Biology 162, 127-138.
168. Winkelhake, J. L., Gauny, S. S., Senyk, G., Piazza, D. & Stevens, P. (1992). Human monoclonal antibodies to glycolipid A that exhibit complement species-specific effector functions. Journal of Infectious Diseases 165, 26-33.
169. Wood, D. M., Parent, J.B., Gazzano-Sontoro, H. & 7 other authors (1992). Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circulatory Shock 38, 55-62.
170. Wright, S.D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J.& Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
171. Wurfel, M. M., Kunitake, S.T., Lichenstein, H., Kane, J. P.& Wright, S.D. (1994). Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. Journal of Experimental Medicine 180, 1025-1035.
172. Xie, Y., von Gavel, S., Cassady, A. I., Stacey, K. J., Dunn, T. L. & Hume, D. A. (1993). The resistance of macrophage-like tumour cell lines to growth inhibition by lipopolysaccharide and pertussis toxin. British Journal of Haematology 84, 392-401.
173. Yang, R.B., Mark, M. R., Gray, A.& 7 other authors (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395, 284-288.
174. Yu, B.& Wright, S.D. (1996). Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. Journal of Biological Chemistry 271, 4100-4105.
175. Zabel, P., Wolter, D.T., Schönharting, M.& Schade, F.U. (1989). Oxpentifylline in endotoxaemia. Lancet 2, 1474-1477.
176. Zähringer, U., Lindner, B. & Rietschel, E. Th. (1994). Molecular structure of lipid A. The endotoxic center of bacterial lipopolysaccharides. Advances in Carbohydrate Chemistry and Biochemistry 50, 211-276.
177. Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E. & Braude, A. I. (1973). Treatment of E. coliand Klebsiella bacteremia in agranulocytic animals with antiserum to a Udp-Gal epimerase-deficient mutant. Journal of Immunology 111, 433-438.
178. Ziegler, E. J., McCutchan, J. A., Douglas, H.& Braude, A. I. (1975). Prevention of lethal pseudomonas bacteremia with epimerasedeficient E. coliantiserum. Transactions of the Association of American Physicians 88, 101-108.
179. Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H. & Braude, A. I. (1982). Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. New England Journal ofMedicine 307, 1225-1230.
180. Ziegler, E. J., Fisher, C. J., Jr., Sprung, C. L., 12 other authors & HA-1A sepsis study group (1991). Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. New England Journal ofMedicine 324, 429-436.